295 related articles for article (PubMed ID: 31940047)
1. A New Generation of Treatments for Itch.
Fowler E; Yosipovitch G
Acta Derm Venereol; 2020 Jan; 100(2):adv00027. PubMed ID: 31940047
[TBL] [Abstract][Full Text] [Related]
2. Small molecule drugs for the treatment of pruritus in patients with atopic dermatitis.
Soeberdt M; Kilic A; Abels C
Eur J Pharmacol; 2020 Aug; 881():173242. PubMed ID: 32504692
[TBL] [Abstract][Full Text] [Related]
3. Drugs on the Horizon for Chronic Pruritus.
McEwen MW; Fite EM; Yosipovitch G; Patel T
Dermatol Clin; 2018 Jul; 36(3):335-344. PubMed ID: 29929605
[TBL] [Abstract][Full Text] [Related]
4. Novel drugs for the treatment of chronic pruritus.
Pereira MP; Ständer S
Expert Opin Investig Drugs; 2018 Dec; 27(12):981-988. PubMed ID: 30426802
[TBL] [Abstract][Full Text] [Related]
5. Medical treatment of pruritus.
Ständer S; Weisshaar E
Expert Opin Emerg Drugs; 2012 Sep; 17(3):335-45. PubMed ID: 22870909
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms and Management of Itch in Dry Skin.
Moniaga CS; Tominaga M; Takamori K
Acta Derm Venereol; 2020 Jan; 100(2):adv00024. PubMed ID: 31940044
[TBL] [Abstract][Full Text] [Related]
7. Systemic kappa opioid receptor agonists in the treatment of chronic pruritus: a literature review.
Phan NQ; Lotts T; Antal A; Bernhard JD; Ständer S
Acta Derm Venereol; 2012 Sep; 92(5):555-60. PubMed ID: 22504709
[TBL] [Abstract][Full Text] [Related]
8. [Modern systemic therapy for pruritus].
Metz M; Pereira MP
Hautarzt; 2020 Jul; 71(7):518-524. PubMed ID: 32399670
[TBL] [Abstract][Full Text] [Related]
9. Trp channels and itch.
Sun S; Dong X
Semin Immunopathol; 2016 May; 38(3):293-307. PubMed ID: 26385480
[TBL] [Abstract][Full Text] [Related]
10. Antidepressants as antipruritic agents: A review.
Kaur R; Sinha VR
Eur Neuropsychopharmacol; 2018 Mar; 28(3):341-352. PubMed ID: 29456150
[TBL] [Abstract][Full Text] [Related]
11. [Therapy for chronic pruritus-light at the end of a long tunnel?].
Pereira MP; Salzmann S; Ständer S; Staubach P; Metz M
Internist (Berl); 2020 Oct; 61(10):1076-1086. PubMed ID: 32676722
[TBL] [Abstract][Full Text] [Related]
12. Antipruritic treatment with systemic μ-opioid receptor antagonists: a review.
Phan NQ; Bernhard JD; Luger TA; Ständer S
J Am Acad Dermatol; 2010 Oct; 63(4):680-8. PubMed ID: 20462660
[TBL] [Abstract][Full Text] [Related]
13. Current and emerging systemic treatments targeting the neural system for chronic pruritus.
Golpanian RS; Yosipovitch G
Expert Opin Pharmacother; 2020 Sep; 21(13):1629-1636. PubMed ID: 32515664
[TBL] [Abstract][Full Text] [Related]
14. Use of Butorphanol as Treatment for Cholestatic Itch.
Golpanian RS; Yosipovitch G; Levy C
Dig Dis Sci; 2021 May; 66(5):1693-1699. PubMed ID: 32556969
[TBL] [Abstract][Full Text] [Related]
15. Advances in therapeutic strategies for the treatment of pruritus.
Stull C; Lavery MJ; Yosipovitch G
Expert Opin Pharmacother; 2016; 17(5):671-87. PubMed ID: 26630350
[TBL] [Abstract][Full Text] [Related]
16. Emerging drugs for the treatment of pruritus.
Ständer S; Weisshaar E; Raap U
Expert Opin Emerg Drugs; 2015 Sep; 20(3):515-21. PubMed ID: 26027744
[TBL] [Abstract][Full Text] [Related]
17. New therapies for controlling atopic itch.
Furue M; Kadono T
J Dermatol; 2015 Sep; 42(9):847-50. PubMed ID: 26332459
[TBL] [Abstract][Full Text] [Related]
18. Challenges in Clinical Research and Care in Pruritus.
Pereira MP; Zeidler C; Storck M; Agelopoulos K; Philipp-Dormston WG; Zink A; Ständer S
Acta Derm Venereol; 2020 Jan; 100(2):adv00028. PubMed ID: 31940048
[TBL] [Abstract][Full Text] [Related]
19. Fibrates for the treatment of cholestatic itch (FITCH): study protocol for a randomized controlled trial.
Bolier R; de Vries ES; Parés A; Helder J; Kemper EM; Zwinderman K; Elferink RPO; Beuers U;
Trials; 2017 May; 18(1):230. PubMed ID: 28535810
[TBL] [Abstract][Full Text] [Related]
20. Role of Pregabalin in Management of Pruritus: A Literature Review.
Foroutan N; Nikvarz N
J Pharm Pharm Sci; 2016; 19(4):465-474. PubMed ID: 28057164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
